Isoniazid-induced serum sickness: Report of caseJournal of the American Osteopathic Association
AbstractAn unusual case of isoniazid (INH)-induced serum sickness is reported. A review of the literature shows that one patient in five who are receiving INH will experience the development of antinuclear antibodies (ANA). A positive ANA test does not warrant discontinuation of INH unless symptoms of systemic lupus erythematosus are present.
Citation InformationJohn P. Simelaro, J. Dale and D. Guest. "Isoniazid-induced serum sickness: Report of case" Journal of the American Osteopathic Association Vol. 80 Iss. 5 (1981) p. 348 - 349
Available at: http://works.bepress.com/john_simelaro/5/